Cite
APA Citation
Wildiers, H., Tryfonidis, K., Dal Lago, L., Vuylsteke, P., Curigliano, G., Waters, S., Brouwers, B., Altintas, S., Touati, N., Cardoso, F., & Brain, E. (2018). pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. Lancet oncology, 19(3), 323–336. http://access.bl.uk/ark:/81055/vdc_100057440631.0x000006